SII asks govt to reduce time gap for Covishield booster dose to six months
Adar Poonawalla, CEO, SII also pitched for a global pact for vaccine utilisation
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Covishield
ICMR study has shown rise in antibodies post Covaxin booster dose: MoS Health tells RS
International data available on booster doses of AstraZeneca and Covishield suggests a three-to four-fold increase in antibody…
Data required for suggesting mixing of COVID-19 vaccine: Government
CDSCO has granted permission to CMC, Vellore, to conduct phase-IV study with Covishield and Covaxin to compare immunogenicity of…
AIIMS Delhi to start booster dose trial of intranasal COVID vaccine from today
The booster dose will be given to those who have received both the doses of either Covaxin or Covishield at least five months ago,…
Centre places purchase order for five crore doses of Corbevax COVID vaccine each costing Rs 145 sans…
The government is yet to decide on which segment of beneficiaries this new vaccine would be administered
SII urges health minister to reduce gap between Covishield’s second and precaution dose from…
The company also requested the minister to allow it to administer Covishield’s precaution dose for all individuals aged above 18…
DCGI approves “Conditional Market Authorisation” of Covaxin and Covishield
The approval pathways through this route are fast-tracked with certain conditions to enhance the access to certain pharmaceuticals…
Each dose of Covishield and Covaxin likely to be capped at Rs 275 after getting regular market…
National Pharmaceutical Pricing Authority (NPPA) has been directed to start working towards capping the price to make the vaccines…
Bharat Biotech seeks full marketing approval from DCGI for Covaxin
The company, however, is yet to submit the full follow up data of clinical trial of Covaxin to DCGI, a source said.
DCGI seeks more data from SII over its application seeking emergency authorisation for Covovax
Serum Institute of India (SII) had sent an application to the DCGI in October for the grant of market authorisation of Covovax for…